FDA Clearance Tracker · P150033-S217
Micra Transcatheter Pacing Systems
Last checked: Nov 20, 2026Latest source record: Nov 25, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 25, 2025
Approved
Time to decision
96 days
Received Aug 21, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150033-S217
- Device name
- Micra Transcatheter Pacing Systems
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Aug 21, 2025
- Decided
- Nov 25, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P150033
Device type
- Device type
- Leadless pacemaker (PNJ)
- Device class
- Class III
- Regulation
- 21 CFR 870.3610
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for labeling updates to reflect the results of the Micra Jugular Access PAS
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.